Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
910.7 DKK | +1.10% | -0.52% | +17.93% |
Feb. 27 | Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024. | CI |
Feb. 14 | COLOPLAST : Q1 24: Many more positives beyond the margin beat |
Business Summary
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Number of employees: 15,751
Sales per Business
DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chronic Care
69.3
%
| 16,263 | 72.0 % | 16,982 | 69.3 % | +4.42% |
Advanced wound Dressings
11.6
%
| 2,689 | 11.9 % | 2,830 | 11.6 % | +5.24% |
Interventional Urology
10.9
%
| 2,424 | 10.7 % | 2,674 | 10.9 % | +10.31% |
Voice and Respiratory Care
7.9
%
| 1,203 | 5.3 % | 1,939 | 7.9 % | +61.18% |
Biologics
0.3
%
| - | - | 75 | 0.3 % | - |
Sales per region
DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other - European Markets
30.6
%
| 7,050 | 31.2 % | 7,498 | 30.6 % | +6.35% |
United States
21.0
%
| 4,269 | 18.9 % | 5,143 | 21.0 % | +20.47% |
Other - Emerging Markets
16.7
%
| 3,900 | 17.3 % | 4,100 | 16.7 % | +5.13% |
United Kingdom
14.0
%
| 3,086 | 13.7 % | 3,433 | 14.0 % | +11.24% |
France
10.8
%
| 2,462 | 10.9 % | 2,634 | 10.8 % | +6.99% |
Other Developed Markets
5.5
%
| 1,531 | 6.8 % | 1,357 | 5.5 % | -11.37% |
Denmark
1.4
%
| 302 | 1.3 % | 335 | 1.4 % | +10.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 07-12-31 | |
Director of Finance/CFO | 52 | 05-12-31 | |
Chairman | 65 | 87-12-31 | |
Allan Rasmussen
COO | Chief Operating Officer | 57 | 91-12-31 |
Thomas Barfod
BRD | Director/Board Member | 53 | 90-12-31 |
Investor Relations Contact | - | 15-12-31 | |
Dorthe Ronnau
HRO | Human Resources Officer | 58 | 22-04-30 |
Paul Marcun
PRN | Corporate Officer/Principal | 58 | 14-12-31 |
Sales & Marketing | - | 86-12-31 | |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 68-09-30 | |
Carsten Hellmann
BRD | Director/Board Member | 60 | 17-11-30 |
Chairman | 65 | 87-12-31 | |
Thomas Barfod
BRD | Director/Board Member | 53 | 90-12-31 |
Director/Board Member | 59 | 19-12-31 | |
Director/Board Member | 55 | 15-11-30 | |
Director/Board Member | 54 | 17-12-31 | |
Director/Board Member | 62 | 17-12-31 | |
Annette Brüls
BRD | Director/Board Member | 53 | 20-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 18,000,000 | 0 | 0 | 58.39 % |
Stock B | 1 | 210,200,000 | 133,245,405 ( 63.39 %) | 3,375,175 ( 1.606 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
COLOPLAST A/S 1.68% | 3,539,528 | 1.68% | 478,769,795 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Coloplast Belgium NV
| |
Coloplast (India) Pvt Ltd.
| |
Coloplast Finance BV
|
Finance/Rental/Leasing
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.68% | 28.89B | |
-33.77% | 2.83B | |
-9.69% | 2.7B | |
-3.98% | 2.01B | |
-2.59% | 1.88B | |
-14.94% | 1.79B | |
-9.44% | 1.37B | |
-4.26% | 1.23B | |
+14.05% | 1.13B | |
-1.70% | 1.02B |
- Stock Market
- Equities
- COLO B Stock
- Company Coloplast A/S